Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000892569-03-000654
Filing Date
2003-03-14
Accepted
2003-03-14 16:23:11
Documents
11
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K YEAR ENDED DECEMBER 31, 2002 a87937e10vk.htm 10-K 1446915
3 EXHIBIT 3.5 a87937exv3w5.txt EX-3.5 1877
4 EXHIBIT 10.6 a87937exv10w6.txt EX-10.6 222356
5 EHXIBIT 10.7 a87937exv10w7.txt EX-10.7 309842
6 EXHIBIT 10.8 a87937exv10w8.txt EX-10.8 212754
7 EXHIBIT 10.13 a87937exv10w13.txt EX-10.13 7238
8 EXHIBIT 10.18 a87937exv10w18.txt EX-10.18 7521
9 EXHIBIT 10.21 a87937exv10w21.txt EX-10.21 17511
10 EXHIBIT 10.22 a87937exv10w22.txt EX-10.22 75035
11 EXHIBIT 21 a87937exv21.txt EX-21 5886
12 EXHIBIT 23 a87937exv23.txt EX-23 1842
  Complete submission text file 0000892569-03-000654.txt   2311433
Mailing Address P.O. BOX 19534 IRVINE CA 92713-9534
Business Address 2525 DUPONT DRIVE IRVINE CA 92612 7142464500
ALLERGAN INC (Filer) CIK: 0000850693 (see all company filings)

EIN.: 951622442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10269 | Film No.: 03604361
SIC: 2834 Pharmaceutical Preparations